5-Fluorocytosine therapy.
D000328:Adult; D000935:Antifungal Agents / Q000627:therapeutic use*; D002555:Cerebrospinal Fluid / Q000382:microbiology; D003454:Cryptococcus / Q000188:drug therapy* / Q000209:etiology; D003455:Cryptococcus neoformans / Q000187:drug effects / Q000302:isolation & purification; D003596:Cytosine / Q000627:therapeutic use*; D004352:Drug Resistance, Microbial; D005437:Flucytosine / Q000008:administration & dosage / Q000009:adverse effects; D006801:Humans; D008297:Male; D008581:Meningitis / Q000188:drug therapy*; D013921:Thrombocytopenia / Q000139:chemically induced
D000935:Antifungal Agents; D003596:Cytosine; D005437:Flucytosine